This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
4 - 6 June, 2024
Excel London Platinum Suite

Erik Aarntzen, MD, PhD
Professor at Radboud University Medical Centre


Dr. Aarntzen worked as a resident Internal Medicine at the Radboudumc in Nijmegen, The Netherlands, from 2008 to 2012. He defended his PhD thesis titled ‘Monitoring immune responses to dendritic cell-based vaccination, with a focus on in vivo imaging’ with honors in 2013. After completion of his residency in Nuclear Medicine in 2017, he now holds a permanent staff position at the Department of Medical Imaging at the Radboudumc. His research group on Immune Imaging performs several clinical studies with a strong translational focus, mainly in the field of onco-immunology. In these studies, multiple tracers, ranging from radiolabeled nanoparticles, autologous immune cells to therapeutic antibodies and small peptides are exploited to better understand the critical components of the tumor microenvironment at both local and system level.

Dr. Aarntzen4 is also one of the founders and current co-chair of the European Society for Molecular Imaging (ESMI) study group Onco-Immunology and Therapy, and former board member of the European Association for Nuclear Medicine (EANM) committee Infection and Inflammation.

Agenda Sessions

  • Exploring [89Zr]Zr-crefmirlimab Berdoxam PET Imaging in a Range of Immune Mediated Conditions